Schedule 13G ownership disclosure
VERRICA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 92511W108
Event date: 2018-06-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.7600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-18-000525
- Form type
- SC 13G
- Filer
- OrbiMed Capital GP VI LLC
- CIK
- CIK 1682115
- Filed
- Jun 25, 2018
- Reporting period
- Jun 19, 2018
- Description
- Schedule 13G beneficial ownership